Upon writing my post I made some speculations regarding the number and how one can achieve a relative risk reduction (RRR) of 94%. However, I made some egregious errors in my assumptions regarding RRR, and didn’t take into account the actual baseline population values included within the SURMOUNT-1 study.
Therefore, a few assumptions were made that aren’t applicable to this situation and would be inaccurate, and thus I chose to unpublish the post due to these calculation errors.
I’ll wait until Eli Lilly releases more information regarding their findings some time in November. For now, apologies to readers as I shouldn’t have overlooked such an egregious error in my interpretation!
Share this post
Unpublished: Tirzepatide reduces diabetes risk?
Share this post
Recently I just made a post regarding Eli Lilly’s press release regarding the so-called “94% reduction” in progression to diabetes.
https://investor.lilly.com/news-releases/news-release-details/tirzepatide-reduced-risk-developing-type-2-diabetes-94-adults
Upon writing my post I made some speculations regarding the number and how one can achieve a relative risk reduction (RRR) of 94%. However, I made some egregious errors in my assumptions regarding RRR, and didn’t take into account the actual baseline population values included within the SURMOUNT-1 study.
Therefore, a few assumptions were made that aren’t applicable to this situation and would be inaccurate, and thus I chose to unpublish the post due to these calculation errors.
I’ll wait until Eli Lilly releases more information regarding their findings some time in November. For now, apologies to readers as I shouldn’t have overlooked such an egregious error in my interpretation!